The expression of the interferon-induced antiviral state was studied in heterokaryons and cytoplasmic hybrids (cybrids The interferons are glycoproteins that are produced and released by cells in response to viral infections and certain other agents (e.g., polyinosinic acid-polycytidylic acid and other doublestranded RNAs). The interferon released by treated cells can interact with untreated cells and cause them to enter an antiviral state in which they are resistant to viral infection. Interferon action involves binding of interferon to the cell membrane, an event that causes a number of alterations in the plasma membrane (6, 8) . However, the relationship of these changes to establishment of the antiviral state is unclear. Induction of the antiviral state by interferon requires the presence of genetic information and does not occur in cells that are exposed to interferon after enucleation (18) . After establishment of the antiviral state, however, the cell nucleus is no longer necessary for its maintenance (18) . It has been reported that in human x mouse hybrid cells the presence of human chromosome 21 alone is sufficient for induction of the antiviral state by human interferon, but the sensitivity of such hybrids to human interferon is significantly less than that of the parental human cell and somewhat less than that of hybrid cells containing more human chromosomes (20) . Induction of the antiviral state by interferon also requires transcription and probably protein synthesis and has been correlated with an increase in the intracellular level of cyclic AMP (9, 16, 23) .
The induction of the antiviral state by interferon appears to be a species-specific phenomenon in most cases; that is, interferon produced by cells of one species will induce the antiviral state in cells of the same species but not in cells of different species (24) . This species specificity is not universal, however. For example, interferon produced by human amnion cells induced the antiviral state in rat embryo fibroblasts (6) . It is unknown whether the species specificity of interferon action is a result of the specificity of surface receptors for interferon or whether it is dependent upon some other event that occurs after the initial binding of interferon. The finding that there is significant binding of some interferons to cells in which they do not induce an antiviral state and also that there are significant alterations in the plasma membrane in these cases suggests that species specificity of interferon action does not result simply from specificity of interferon binding (14) .
The experiments described in this paper were designed to answer the following questions regarding the species specificity of interferon ac- Preparation of vaccinia virus. Confluent HeLa cells in large bottles were infected with vaccinia virus (WR strain) at a multiplicity of infection of 2 PFU/ cell and incubated for 2 to 3 days. The cells were generally detached from the growth substrate at that time and were collected by centrifugation from the growth medium. The cells were broken by Dounce homogenization in EMEM diluted 1:10 with water, and nuclei were removed by centrifugation (500 x g, 10 min). The supernatant suspension was centrifuged at 40,000 x g for 1 h, and the pellet of crude virus was suspended in phosphate-buffered saline minus magnesium, supplemented with 1% bovine serum albumin (1 ml/107 original cells). After suspension, the virus was sonicated, dispensed in 1-ml portions, and stored at -700C.
The virus was titrated in one of two ways: (i) by plaque assay on a human cell line (T98G) (21) (25) . Conditions for enucleation were as follows. Standard growth medium was replaced with growth medium supplemented with 10 Ag of cytochalasin B per ml (CB medium), and the cells were subjected to centrifugation at 16,300 x g. L cells were routinely 95 to 98% enucleated; HeLa cells were 80 to 90% enucleated. After centrifugation, CB medium was replaced with standard growth medium, and the enucleated cells (cytoplasts) were allowed to recover from the effects of the CB medium before being trypsinized and fused with whole cells. In a few experiments, cytoplasts were not trypsinized before fusion with whole cells. In those cases, cells were grown and enucleated on plastic disks cut from tissue culture ware. Cells on the plastic disks were enucleated at 20,400 x g in plastic tubes containing 8 ml of CB medium.
Cell fusion. Cellular fusions and cell x cytoplast fusions were performed as follows. The different cell types were mixed in modified Hanks solution (Hanks solution minus glucose and bicarbonate buffered with 0.01 M Tris to pH 7.6) and then chilled in an ice water bath. UV-inactivated Sendai virus was added to a final concentration of 100 hemagglutinating units per ml and allowed to adsorb for 3 min in the ice water bath. 
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The final volume of the fusion mixture was approximately 0.5 ml. The cell-virus mixture was then incubated in a 37°C water bath for 30 min. After fusion, standard growth medium was added to the fusion mixture and cells were removed by centrifugation, resuspended in growth medium, and plated on glass cover slips in 35-mm tissue culture dishes.
Cells that were enucleated on plastic disks were fused to whole cells in a mixed monolayer-suspension system. Sendai virus (0.1 ml, 1,000 hemagglutinating units per ml) was added to chilled cytoplasts for 20 min at 4°C and then removed. Whole cells were then added (ca. 2 x 105 cells in 0.1 ml), and the disks were incubated for an additional 20 min at 4°C. Prewarmed medium (2.5 ml) was then carefully added, the fusion mixture was incubated at 37°C for 20 min, and the cover slips were vigorously washed and placed into normal growth medium or growth medium containing interferon.
Assay of the antiviral state. The antiviral state was assayed by scoring the presence or absence of cytoplasmic DNA factories after cells were infected with vaccinia virus, labeled with [3H]thymidine, and subjected to autoradiography.
Cells that had been plated on glass cover slips in 35-mm dishes were washed twice with calcium-free phosphate-buffered saline. Vaccinia virus was added to the dishes in 0.6 ml of calcium-free phosphatebuffered saline. Virus was allowed to adsorb for 30 min at 37°C and was then removed, and the cells were washed with calcium-free phosphate-buffered saline. Cells were incubated in standard growth medium for 1 h and then in growth medium containing [3H]thymidine at a concentration of 2 ,uCi/ml (40 Ci/mmol) for 2.5 h. The cells were then fixed with ethanol-acetic acid (3:1), air dried, hydrolyzed with 1 N HCl, air dried again, and the cover slips were attached to glass slides. Mounted cover slips were dipped in NTB-2 emulsion (Kodak), exposed for 5 days, developed with D19 or Dektol (Kodak), and stained with Giemsa. The slides were examined with a light microscope, and individual cells were scored for the presence or absence of DNA factories. When whole cell x cytoplast hybrids were being scored, only those cells which clearly contained a single nucleus and latex spheres of both sizes were counted. When homokaryons or heterokaryons were being scored, cells containing two or more nuclei and latex spheres of both sizes were counted. The number of cells scored for each experiment varied, depending on the quality of the individual slides and the resultant ease with which they could be scored. In the experiments described below, the number of cells counted for each experimental condition was 150 to 400 for whole cells, 100 to 350 for heterokaryons, and 50 to 200 for cytoplasmic hybrids (cybrids).
Statistical analysis. We compared the frequencies of viral infection (determined by the assay described above) in the different cell populations with contingency tables. In essence, we tested the hypothesis that the frequency of infection was independent of the cellular treatment or cellular constitution. The rejection of this hypothesis at the 0.05 level of significance was interpreted as a difference between the cell populations. The populations compared and the results of the analysis are noted throughout the text, tables, and figures that follow.
RESULTS
Properties of the assay system for the antiviral state. The experiments that we wished to perform seemed to require an examination of the resistance to virus growth in subpopulations of cells in a mixture of cell types. Therefore, we chose an autoradiographic assay for the antiviral state in which the different populations of cells could be identified and their resistance to virus growth could be, at least qualitatively, determined. We chose to use vaccinia virus as the challenge virus and to use the number of cells displaying cytoplasmic DNA factories as an estimation of their ability to be infected by the virus (determined as described above).
From the results of our early experiments, it was apparent that the expression of the antiviral state in our L cells and HeLa cells was not an all-or-none phenomenon. With each cell line, the number of cells displaying cytoplasmic DNA synthesis was dependent upon the concentration of interferon with which the cells were treated, the concentration of the virus with which they were infected, and the time in the infectious cycle during which the cells were allowed to incorporate radioactive thymidine. From these early experiments, we chose to treat L cells with more than 100 U of mouse interferon per ml and HeLa cells with more than 80 U of human interferon per ml. In all experiments we used a mul tiplicity of infection of 5 to 10 for vaccinia viruses (see above), and we allowed the cells to incorporate radioactive thymidine from 1 to 3.5 h after virus adsorption. We chose these conditions because of the following: (i) the interferontreated cells were reproducibly less infected with the virus, (ii) a substantial fraction of untreated cells was detectably infected in the assay system, and (iii) the difference between interferontreated and untreated cells was most apparent.
An example of the results of such an early experiment is shown in Fig. 1 Test of the dominance of the antiviral state after fusion with homologous or heterologous whole cells. L cells labeled with latex spheres were treated overnight with mouse interferon (1,000 U/ml, 4 ml) and then mixed or fused with untreated L cells labeled with spheres of a different size. After mixture or fusion, the cells were plated, allowed to attach to glass cover slips for 1 to 1.5 h, infected with vaccinia virus, and assayed as described above. Figure 2A shows three homokaryons after such treatment. Mixed and fused preparations were scored for infection of homokaryons containing latex spheres of both sizes and for infection of parental cells (cells containing a single bead size). As shown in Fig.  2B , such homokaryons were protected from vaccinia virus infection to the same degree that interferon-treated whole cells were. The percentage of treated and untreated cells that were infected by vaccinia virus was not statistically significantly different for the mixed and fused preparations, indicating that the cells appeared to exhibit protection from vaccinia virus infection because of the prior interferon treatment rather than exposure to Sendai virus.
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HeLa cells were subjected to the same type of treatment. One population of HeLa cells was treated with human interferon (438 U/ml) for 18 h and mixed or fused with an untreated population of HeLa cells containing a different size of latex spheres as a cytoplasmic label. After the cells were plated and attached (ca. 1 to 1.5 h), they were infected with vaccinia virus and assayed as described above. The results of such an experiment (Fig. 3) were similar to those for L cells (Fig. 2B) Fig. 2B, Fig. 3, and Table 3 . Interferon-treated (600 U of mouse interferon per ml, 4 ml, overnight incubation) and untreated L cells were enucleated (see above) and plated or plated as whole cells, allowed to attach for 1 to 1.5 h, infected with vaccinia virus, and assayed as described above. In this experiment, cells and cytoplasts were radioactively labeled between 1 and 6 h after the period of viral adsorption. As shown in Table 3 The second type of control was a repeat of the fusion of cytoplasts to whole cells. In this case, however, the cytoplasts were derived from cells not treated with interferon. The results of such an experiment are shown in Table 4 . The cybrids were not more resistant to vaccinia virus infection than were the parental whole cells.
Effects of treating HeLa cell x L cell heterokaryons with human or mouse or both a In experiment 1, mouse interferon was 2,900 U/ ml, 2 ml; human interferon was 1,500 U/ml, 2 ml; combination was 1,450 U of mouse interferon per ml and 750 U of human interferon per ml, 2 ml. In experiment 2, mouse interferon was 5,000 U/ml, 2 ml; human interferon was 570 U/ml, 2 ml; combination was 5,000 U of mouse interferon per ml and 570 U of human interferon per ml, 2 ml. were treated overnight with human interferon or mouse interferon or were left untreated. Cells were then infected with vaccinia virus, assayed, and scored as described above. In each experiment, whole cells from which the cytoplasts were derived were similarly treated and assayed to determine the effectiveness of the interferon homospecific for that cell type. Figure 5 shows the results of an experiment involving whole HeLa cells and L cell cytoplasts, and Fig. 6 shows the results of an experiment involving whole L cells and HeLa cell cytoplasts. In both experiments, cybrids entered the antiviral state in response to treatment with interferon homospecific for the whole cell involved in the fusion, but did not enter the antiviral state in response to treatment with interferon homospecific for the cytoplast involved in the fusion.
We were concerned that these results might be due, at least in part, to loss of interferon binding sites from cytoplasts when they were trypsinized from flasks after enucleation. To eliminate this potential problem, we performed experiments in which cells were enucleated on plastic disks, fused to whole cells, and treated with interferon before being trypsinized and plated onto glass cover slips. Cybrids formed by this technique still failed to respond significantly to interferon homospecific for the cytoplasts involved in the fusion (unpublished data). HeLa cells were fused with L cell cytoplasts, and the resulting cellpreparations were treated overnight with human interferon (104 U/ml, 2 ml) or mouse interferon (6,309 U/ml, 2 We wish to make several points about the assay system. First, a statistically significant difference (P < 0.01) is found between interferontreated and untreated cell populations over a fivefold range of interferon concentrations and a fourfold range of vaccinia virus concentrations which we tried in the assay system (unpublished data). The conditions that we used here are rather arbitrary. Second, most of the experiments that we performed involve a comparison of cell populations. These populations are present in the same cover slip culture, and variations in experimental conditions should be identical for each population. Last, we used the assay only in a qualitative manner; that is, we cannot deduce, in a quantitative fashion, the level of the antiviral state. We can only deduce a statistically significant difference in the number (percentage) of cells with detectable cytoplasmic DNA synthesis.
Two previous autoradiographic studies offered conflicting results concerning the effects of interferon on vaccinia virus infection. The results of the first study indicated that the number of cells showing cytoplasmic factories can be reduced by interferon treatment (10) . The results of the second study indicated that the size of the factories can be reduced, but that the number of cells infected is not nearly so dramatically affected (15) . As shown in Fig. 1 (Table 2 ). An interferon-dependent transfer of virus resistance between L cells and human cells has been described previously (2) . In this described transfer, requirement for metabolic activity of the recipient cells was demonstrated. Some of the effects which we have observed may be caused by similar mechanisms. However, we believe that the inhibition is caused primarily by cytoplasmic factors acting directly because (i) the cells are washed free from interferon and are trypsinized before being fused and (ii) the assay for the antiviral state occurs within 1.5 h after cell fusion. However, we cannot totally exclude that some of the effects that we observe are dependent upon the metabolic activity of the nucleus of the untreated cell. Because of the short time interval between the time of cell fusion and assay of the antiviral state, we also do not believe that the elution of interferon from treated cells and its utilization by untreated cells account for our results. The lack of protection in the population of untreated cells in our preparations is also taken as evidence against this latter hypothesis.
The inhibition of protein synthesis in interferon-treated cells has been correlated with the production of a unique nucleotide (pppA2'p5'A2'p5'A) and with the appearance of a protein kinase that phosphorylates one of the initiation factors in protein synthesis (1, (11) (12) (13) (14) 26 Our results also show that the factors responsible for expression of the antiviral state as detected by the vaccinia virus assay are located in the cytoplasm and are transferred by cytoplasts (Fig. 4) . The lack of protection in mixed preparations or in cybrids formed from cells not treated with interferon (Table 4) shows that the antiviral condition which is transmitted is dependent upon the prior treatment of cells with interferon.
Treatment of heterokaryons and cybrids with interferon. We tested the ability of heterokaryons to express the antiviral state after treatment with interferon specific for either parental cell type (Table 5) . Heterokaryons generally did not show an increased resistance to vaccinia virus infection compared with cells of the species heterologous to that of the interferon (Table 5 , columns 2 and 3 of experiment 1 and column 3 of experiment 2). At high levels of interferon, the heterokaryons were more sensitive than heterologous cells (Table 5, column 2 of experiment 2). We believe the heterokaryons would have responded to very high levels of human interferon, but such treatment was impractical with our preparation of human interferon. In the absence of a heterologous nucleus (i.e., in cybrids), the cybrids are fully responsive to lower levels of interferon (cf. Table 5 and Fig.  5 ). From these experiments we conclude that the expression of the antiviral state in heterokaryons is inhibited by the presence of a heterologous nucleus.
The nature of this apparent inhibition by a heterologous nucleus is not known. When heterokaryons are treated with both species of interferon simultaneously, the interferons appear to act synergistically (Table 5 , column 4). A synergistic effect was described previously in hybrid cells and was attributed to a membrane effect (3, 6) . A similar membrane-associated mechanism may be responsible for these results. This effect, however, would be dependent upon the continued presence of the heterologous nucleus.
There is considerable evidence that interferon exerts its antiviral effect from the exterior surface of the plasma membrane (for reviews, see references 6 and 8). Genetic data obtained from studies of somatic cell hybrids formed by fusions of mouse and human cells have shown that human chromosome 21 is involved in establishing the antiviral state in response to human interferon (22) . Other data suggest that one product of human chromosome 21 is a specific cell surface receptor (19) , although the latter conclusion has been questioned (7). One attractive hypothesis for the species specificity of interferon action is that species-specific interferon receptors are present on the plasma membrane. Upon interaction with interferon, the conformation of the plasma membrane is altered, ultimately resulting in the intracellular alterations which bring about derepression of the genes responsible for expression of the antiviral state. Just as the intracellular mediators of the antiviral state may not be species specific, the intracellular alterations which bring about derepression of genes responsible for expression of the antiviral state may not be species specific (5). Indeed, it has been suggested by one investigator that "the cell species specificity of interferon is solely due to the receptor site" (6) .
In an attempt to verify this hypothesis directly, we formed cybrids between mouse and human cells and attempted to induce the antiviral state in the cybrids by treating them with interferon specific for the species from which the cytoplasts were derived. We reasoned that the cybrids would possess the cytoplasm and the plasma membrane (i.e., the interferon receptor VOL. 31, 1979 on October 19, 2017 by guest http://jvi.asm.org/ Downloaded from sites) of the species from which the cytoplasts were derived and would therefore be able to respond to interferon of that species.
In these experiments, we treated the cybrids with relatively low concentrations of interferon homospecific for the parental whole cells and relatively high concentrations of interferon for the cytoplast parent in an attempt to detect a transfer of species specificity via the cytoplast. If the hypothesis were correct, the detected infection of the cybrid should have been different from that of the parental whole cell when treated with interferon specific for the cytoplast parent. As shown in Fig. 5 
